A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

Clinical trial NCT06382155 · RECRUITING

Trial details

NCT number: NCT06382155
Sponsor: BioMarin Pharmaceutical
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Short Stature

Start date: 2024-10-21
Primary completion: 2026-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.